2016
DOI: 10.1007/s00210-016-1231-9
|View full text |Cite
|
Sign up to set email alerts
|

Tetrodotoxin-sensitive α-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anesthetics

Abstract: The sodium channel α-subunit (Nav) Nav1.5 is regarded as the most prevalent cardiac sodium channel required for generation of action potentials in cardiomyocytes. Accordingly, Nav1.5 seems to be the main target molecule for local anesthetic (LA)-induced cardiotoxicity. However, recent reports demonstrated functional expression of several "neuronal" Nav's in cardiomyocytes being involved in cardiac contractility and rhythmogenesis. In this study, we examined the relevance of neuronal tetrodotoxin (TTX)-sensitiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
1
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 40 publications
1
1
0
Order By: Relevance
“…Remarkably, when experimentally tested tafluprost blocked the corresponding currents at both NaV1.5 and TASK-1, although with a higher potency for the latter. The differential activity of tafluprost upon both ion channels (as well as its higher potency as compared with the local anesthetic bupivacaine (Stoetzer et al, 2016)) roughly agrees with the theoretical binding energies predicted by the docking simulations. Noteworthy, although tafluprost was clearly less active in NaV1.5 than in TASK-1, it still shows a potency in a similar range as that shown by the well-known sodium channel blocker bupivacaine (Zhang et al, 2014).…”
Section: Discussionsupporting
confidence: 75%
“…Remarkably, when experimentally tested tafluprost blocked the corresponding currents at both NaV1.5 and TASK-1, although with a higher potency for the latter. The differential activity of tafluprost upon both ion channels (as well as its higher potency as compared with the local anesthetic bupivacaine (Stoetzer et al, 2016)) roughly agrees with the theoretical binding energies predicted by the docking simulations. Noteworthy, although tafluprost was clearly less active in NaV1.5 than in TASK-1, it still shows a potency in a similar range as that shown by the well-known sodium channel blocker bupivacaine (Zhang et al, 2014).…”
Section: Discussionsupporting
confidence: 75%
“…Several studies reported that other Na v 1. x isoforms may be expressed in cardiac cells in addition to Na v 1.5, such as Na v 1.1 (Westenbroek et al, 2013), Na v 1.2 (Stoetzer et al, 2016), Na v 1.3 (Westenbroek et al, 2013), Na v 1.4 (Westenbroek et al, 2013), Na v 1.6 (Westenbroek et al, 2013), and Na v 1.8 (Yang et al, 2012). Although we performed the aforementioned I Na recordings in the presence of 50 nM TTX, which efficiently inhibits Na v 1.1 (IC 50 ∼10 nM), Na v 1.2 (IC 50 ∼10 nM), Na v 1.3 (IC 50 ∼10 nM), and Na v 1.6 (IC 50 ∼5 nM), I Na from Na v 1.4 (IC 50 ∼25 nM) and Na v 1.8 (IC 50 > 50 μM) could still be present.…”
Section: Resultsmentioning
confidence: 99%
“…Kirchhof et al reported that a peptide that activates Nav1.3 and Nav1.6 can induce positive inotropy without provoking arrhythmias [ 7 ]. We have previously demonstrated that Nav1.5 and brain-type subunits are differentially inhibited Na + channel inhibitors including local anesthetics [ 8 ]. Brain-type subunits may also be relevant for the emergence and treatment of arrhythmias [ 9 , 10 , 11 ], and they were suggested to be relevant for the emergence of pro-arrhythmic non-inactivating late Na + currents in cardiomyocytes [ 12 , 13 , 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%